Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

UCL's gene therapy developer has followed a $120m round co-led by Novo three weeks ago by filing to go public on the Nasdaq Global Select Market.

The gene therapy developer has followed a $120m round co-led by Novo three weeks ago by filing to go public on the Nasdaq Global Select Market.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

GlaxoSmithKline is paying $176m for a 10% stake in University of Tübingen's RNA drug developer in connection with a strategic partnership agreement.

GlaxoSmithKline is paying $176m for a 10% stake in the RNA drug developer in connection with a strategic partnership agreement.

Juno Capital has said neither Neil Woodford or Craig Newman have been appointed with the firm, denying earlier reports to the contrary.

Channel 4 Ventures and existing investor BP Ventures contributed to a $25.9m round for the vehicle rental service that will support technology and marketing.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The TTO funded new projects with $4.2m last year and launched 15 new companies under the French Tech Seed program.